Fabio Salamanca-Buentello is a Mexican physician who has worked in molecular genetics of human cancer and in the molecular basis of memory. He is interested in the development and implementation of new technologies in the developing world. He coordinated at the University of Toronto Joint Centre for Bioethics and at the Canadian Program on Genomics and Global Health a project that identified and ranked the ten applications of nanotechnology most likely to benefit the developing world. Due to his previous work as a researcher in genetics, he has also focused on genomic medicine and its impact on global health. He was also Coordinator of the Executive Course on Genomics and Public Health Policy for Latin America and the Caribbean, which was co-organized by the University of Toronto Joint Centre for Bioethics, the Pan American Health Organization, and the United Nations University Program in Biotechnology for Latin America and the Caribbean.
Fabio Salamanca is currently a member of the McLaughlin-Rotman Centre and of the University of Toronto Institute of Medical Science. He is also a member of the Genomics and Nanotechnology Working Group of the United Nations Millennium Project Task Force on Science, Technology and Innovation, and member of the Advisory Board of The Nanoethics Group and of the Editorial Board of the journal NanoEthics: Ethics for Technologies that converge at the nanoscale. He is also a member of a UNESCO Expert Committee on Nanoethics.